• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Scaffold and Parasite Hopping: Discovery of New Protozoal Proliferation Inhibitors.支架与寄生物转移：新型原生动物增殖抑制剂的发现
ACS Med Chem Lett. 2020 Jan 10;11(3):249-257. doi: 10.1021/acsmedchemlett.9b00453. eCollection 2020 Mar 12.
2
Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors.在法呢基转移酶抑制剂上引入 N-苄基咪唑基后，驱虫活性得到极大改善。
Eur J Med Chem. 2016 Feb 15;109:173-86. doi: 10.1016/j.ejmech.2015.12.045. Epub 2015 Dec 29.
3
Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites.抗寄生虫先导物的发现：迈向对多种原生动物寄生虫具有活性的化学类型的优化
ACS Med Chem Lett. 2017 Feb 5;8(3):350-354. doi: 10.1021/acsmedchemlett.7b00011. eCollection 2017 Mar 9.
4
In vitro screening of traditional South African malaria remedies against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and Plasmodium falciparum.体外筛选南非传统疟疾疗法对布氏锥虫、克氏锥虫、杜氏利什曼原虫和恶性疟原虫的作用。
Planta Med. 2011 Sep;77(14):1663-7. doi: 10.1055/s-0030-1270932. Epub 2011 Mar 16.
5
Anti-Protozoal Activities of Cembrane-Type Diterpenes from Vietnamese Soft Corals.越南软珊瑚中松香烷型二萜类化合物的抗寄生虫活性
Molecules. 2015 Jul 8;20(7):12459-68. doi: 10.3390/molecules200712459.
6
Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.用于锥虫增殖的4-苯胺基喹唑啉抑制剂的物理化学性质优化
Eur J Med Chem. 2017 Dec 1;141:446-459. doi: 10.1016/j.ejmech.2017.10.007. Epub 2017 Oct 6.
7
Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.双膦酸盐可抑制布氏锥虫、克氏锥虫、杜氏利什曼原虫、刚地弓形虫和恶性疟原虫的生长：一种潜在的化疗途径。
J Med Chem. 2001 Mar 15;44(6):909-16. doi: 10.1021/jm0002578.
8
Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway.针对恶性疟原虫辅酶A合成途径的化学结构多样化合物的生物学特性研究
Parasit Vectors. 2016 Nov 17;9(1):589. doi: 10.1186/s13071-016-1860-3.
9
Antiprotozoal activities of traditional medicinal plants from the Garhwal region of North West Himalaya, India.印度西北喜马拉雅山脉加瓦尔地区传统药用植物的抗原生动物活性。
J Ethnopharmacol. 2011 Jun 14;136(1):123-8. doi: 10.1016/j.jep.2011.04.024. Epub 2011 Apr 16.
10
Optimization of Physicochemical Properties for 4-Anilinoquinoline Inhibitors of Plasmodium falciparum Proliferation.恶性疟原虫增殖的4-苯胺基喹啉抑制剂的物理化学性质优化
ACS Infect Dis. 2018 Apr 13;4(4):577-591. doi: 10.1021/acsinfecdis.7b00212. Epub 2018 Jan 17.

引用本文的文献

1
4-Aminoquinoline as a privileged scaffold for the design of leishmanicidal agents: structure-property relationships and key biological targets.4-氨基喹啉作为设计抗利什曼原虫药物的优势骨架：结构-性质关系及关键生物学靶点
Front Chem. 2025 Jan 29;12:1527946. doi: 10.3389/fchem.2024.1527946. eCollection 2024.
2
Identification of Substituted 4-Aminocinnolines as Broad-Spectrum Antiparasitic Agents.取代4-氨基噌啉作为广谱抗寄生虫药物的鉴定
ACS Infect Dis. 2025 Mar 14;11(3):584-599. doi: 10.1021/acsinfecdis.4c00666. Epub 2025 Feb 12.
3
Pharmacophore Identification and Structure-Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of .取代氮茚类化合物作为. 抑制剂的药效团识别和构效关系分析
J Med Chem. 2024 Aug 22;67(16):13985-14006. doi: 10.1021/acs.jmedchem.4c00785. Epub 2024 Aug 13.
4
Medicinal polypharmacology-a scientific glossary of terminology and concepts.药用多药理学——术语和概念的科学词汇表。
Front Pharmacol. 2024 Jul 18;15:1419110. doi: 10.3389/fphar.2024.1419110. eCollection 2024.
5
Computer-aided pattern scoring - A multitarget dataset-driven workflow to predict ligands of orphan targets.计算机辅助模式评分 - 一种多靶点数据集驱动的工作流程，用于预测孤儿靶点的配体。
Sci Data. 2024 May 23;11(1):530. doi: 10.1038/s41597-024-03343-8.
6
Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective.用于治疗利什曼病的喹啉骨架的演变：结构视角
Pharmaceuticals (Basel). 2024 Feb 22;17(3):285. doi: 10.3390/ph17030285.
7
Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit.临床中的药物多药理学——将多药药理学转化为治疗益处。
Pharm Res. 2024 Mar;41(3):411-417. doi: 10.1007/s11095-024-03656-8. Epub 2024 Feb 16.
8
Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy.发现 5-苯基吡唑并嘧啶酮类似物作为具有体内疗效的强效抗锥虫药物。
J Med Chem. 2023 Aug 10;66(15):10252-10264. doi: 10.1021/acs.jmedchem.3c00161. Epub 2023 Jul 20.
9
A Novel Protocol for the Synthesis of 1,2,4-Oxadiazoles Active against Trypanosomatids and Drug-Resistant Leukemia Cell Lines.一种合成对锥虫和耐药白血病细胞系具有活性的1,2,4-恶二唑的新方案。
Trop Med Infect Dis. 2022 Nov 28;7(12):403. doi: 10.3390/tropicalmed7120403.
10
Identification of Leucinostatins from sp. as Antiparasitic Agents against .从……中鉴定出亮抑素作为抗……的抗寄生虫剂。 （注：原文中“sp.”和“.”处信息缺失，以上是按格式要求给出的尽量完整译文）
ACS Omega. 2022 Jan 28;7(9):7675-7682. doi: 10.1021/acsomega.1c06347. eCollection 2022 Mar 8.

本文引用的文献

1
Chagas Cardiomyopathy in Latin America Review.拉丁美洲克氏锥虫心肌病综述。
Curr Cardiol Rep. 2019 Feb 12;21(2):8. doi: 10.1007/s11886-019-1095-y.
2
Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development.提高拉帕替尼类似物的水溶性：鉴定一种用于人类非洲锥虫病药物开发的喹啉亚胺先导化合物。
J Med Chem. 2019 Jan 24;62(2):665-687. doi: 10.1021/acs.jmedchem.8b01365. Epub 2019 Jan 10.
3
Anilinoquinoline based inhibitors of trypanosomatid proliferation.基于吖啶酮的利什曼原虫增殖抑制剂。
PLoS Negl Trop Dis. 2018 Nov 26;12(11):e0006834. doi: 10.1371/journal.pntd.0006834. eCollection 2018 Nov.
4
Optimization of Physicochemical Properties for 4-Anilinoquinoline Inhibitors of Plasmodium falciparum Proliferation.恶性疟原虫增殖的4-苯胺基喹啉抑制剂的物理化学性质优化
ACS Infect Dis. 2018 Apr 13;4(4):577-591. doi: 10.1021/acsinfecdis.7b00212. Epub 2018 Jan 17.
5
Leishmaniasis drug discovery: recent progress and challenges in assay development.利什曼病药物发现：检测方法开发的最新进展和挑战。
Drug Discov Today. 2017 Oct;22(10):1516-1531. doi: 10.1016/j.drudis.2017.06.004. Epub 2017 Jun 21.
6
Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites.抗寄生虫先导物的发现：迈向对多种原生动物寄生虫具有活性的化学类型的优化
ACS Med Chem Lett. 2017 Feb 5;8(3):350-354. doi: 10.1021/acsmedchemlett.7b00011. eCollection 2017 Mar 9.
7
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.抗锥虫药物研发：一项持续的挑战与持续的需求。
Nat Rev Microbiol. 2017 Feb 27;15(4):217-231. doi: 10.1038/nrmicro.2016.193.
8
Repurposing strategies for tropical disease drug discovery.热带病药物研发的重新利用策略。
Bioorg Med Chem Lett. 2016 Jun 1;26(11):2569-76. doi: 10.1016/j.bmcl.2016.03.103. Epub 2016 Mar 30.
9
Hit and lead criteria in drug discovery for infectious diseases of the developing world.发展中国家传染病药物研发的命中和先导标准。
Nat Rev Drug Discov. 2015 Nov;14(11):751-8. doi: 10.1038/nrd4683. Epub 2015 Oct 5.
10
Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery.通过交叉筛选发现的原生动物寄生虫生长抑制剂为先导化合物发现提供了有效的骨架。
J Med Chem. 2015 Jul 23;58(14):5522-37. doi: 10.1021/acs.jmedchem.5b00515. Epub 2015 Jul 8.

支架与寄生物转移：新型原生动物增殖抑制剂的发现

Scaffold and Parasite Hopping: Discovery of New Protozoal Proliferation Inhibitors.

作者信息

Singh Baljinder, Bernatchez Jean A, McCall Laura-Isobel, Calvet Claudia M, Ackermann Jasmin, Souza Julia M, Thomas Diane, Silva Everton M, Bachovchin Kelly A, Klug Dana M, Jalani Hitesh B, Bag Seema, Buskes Melissa J, Leed Susan E, Roncal Norma E, Penn Erica C, Erath Jessey, Rodriguez Ana, Sciotti Richard J, Campbell Robert F, McKerrow James, Siqueira-Neto Jair L, Ferrins Lori, Pollastri Michael P

机构信息

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093, United States.

出版信息

ACS Med Chem Lett. 2020 Jan 10;11(3):249-257. doi: 10.1021/acsmedchemlett.9b00453. eCollection 2020 Mar 12.

DOI:10.1021/acsmedchemlett.9b00453
PMID:32184953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7073875/
Abstract

Utilizing a target repurposing and parasite-hopping approach, we tested a previously reported library of compounds that were active against , plus 31 new compounds, against a variety of protozoan parasites including , , and . This led to the discovery of several compounds with submicromolar activities and improved physicochemical properties that are early leads toward the development of chemotherapeutic agents against kinetoplastid diseases and malaria.

摘要

利用靶点重新利用和宿主转换方法，我们测试了一个先前报道的对[未提及的某种物质]有活性的化合物库以及31种新化合物，用于对抗多种原生动物寄生虫，包括[未提及的三种寄生虫名称]。这导致发现了几种具有亚微摩尔活性且理化性质有所改善的化合物，这些化合物是开发针对动基体疾病和疟疾的化疗药物的早期先导物。